Talaris Therapeutics Inc (TALS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | TALS | AMLX | RLMD | ||
| Company | Talaris Therapeutics Inc | Amylyx Pharmaceuticals Inc | Relmada Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 27.80 | 1.7900 | 3.69 | ||
| High | 27.95 | 1.8400 | 3.87 | ||
| Low | 26.90 | 1.7000 | 3.62 | ||
| Last | 27.20 | 1.7600 | 3.83 | ||
| Change | -0.20 | -0.0200 | +0.13 | ||
| % Change | -0.73% | -1.12% | +3.51% | ||
| Volume | 30,520 | 5,218,000 | 80,000 | ||
| 20-Day Average Volume | 179,555 | 2,457,245 | 117,415 | ||
| Previous Close | 27.40 | 1.7800 | 3.70 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 2.76 | 2.2340 | 4.42 | ||
| 20-Day Raw Stochastic | 31.67% | 5.04% | 14.29% | ||
| 20-Day Relative Strength | 46.92% | 23.25% | 38.67% | ||
| Weighted Alpha | +66.50 | -72.30 | +4.76 | ||
| Today's Opinion | Hold | 100% Sell | 8% Buy | ||
| Previous Opinion | 8% Buy | 100% Sell | 8% Buy | ||
| Last Month's Opinion | 48% Buy | 100% Sell | 56% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.74% since 10/12/23 | -5.88% since 04/19/24 | -4.25% since 04/19/24 | ||
| Low | 2.60 on 10/18/23 | 1.7000 on 04/26/24 | 3.62 on 04/26/24 | ||
| High | 3.13 on 10/16/23 | 2.0250 on 04/22/24 | 4.10 on 04/23/24 | ||
| 1-Month | |||||
| %Chg | -6.85% since 09/19/23 | -35.77% since 03/26/24 | -18.34% since 03/26/24 | ||
| Low | 2.53 on 10/10/23 | 1.7000 on 04/26/24 | 3.62 on 04/26/24 | ||
| High | 3.13 on 10/16/23 | 2.9800 on 03/28/24 | 5.09 on 04/09/24 | ||
| 3-Month | |||||
| %Chg | -9.63% since 07/19/23 | -88.56% since 01/26/24 | +5.51% since 01/26/24 | ||
| Low | 2.53 on 10/10/23 | 1.7000 on 04/26/24 | 3.55 on 01/29/24 | ||
| High | 3.13 on 10/16/23 | 19.9488 on 02/29/24 | 7.22 on 03/04/24 | ||
| 6-Month | |||||
| %Chg | +23.64% since 04/19/23 | -88.97% since 10/26/23 | +21.97% since 10/26/23 | ||
| Low | 2.15 on 04/20/23 | 1.7000 on 04/26/24 | 2.41 on 12/01/23 | ||
| High | 3.29 on 07/10/23 | 19.9488 on 02/29/24 | 7.22 on 03/04/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 116,318 | 119,691 | 115,566 | ||
| Shares Outstanding, K | 42,764 | 68,006 | 30,174 | ||
| Annual Sales | 0 | 380,790,000 | 0 | ||
| Annual Net Income | -73,890,000 | 49,270,000 | -98,790,000 | ||
| Last Quarter Sales | 0 | 108,450,000 | 0 | ||
| Last Quarter Net Income | -14,740,000 | 4,730,000 | -25,170,000 | ||
| 60-Month Beta | 2.18 | -0.93 | 0.19 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.20 on 08/14/23 | 0.07 on 02/22/24 | -0.84 on 03/19/24 | ||
| Latest Earnings Date | 11/09/23 | 05/09/24 | 05/09/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | 03/28/18 | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 2.54 | 0.00 | ||